Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 26 Jun 2023 for CTI Biopharma CORP, €30k.
Filing timeline
BuySaleJames K. Fong
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
James K. Fong: trading record in brief
This profile gathers the share dealings of James K. Fong in CTI Biopharma Corp. The record holds 3 filings, for trades running from 24 January 2023 to 26 June 2023.
Every open-market trade on record is a sale: 1 sale worth €552k. Other entries cover 1 option exercise.
Most recently, on 26 June 2023, the filings show a transaction worth €30k in CTI Biopharma Corp. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to James K. Fong
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
3,565 shares@ US$9.1025.4% of flowCommon StockSEC:0000899243-23-016479:0
100,000 shares@ US$6.0082.5% of flowcommon stockSEC:0000891293-23-000003:1
100,000 shares@ US$0.948974.6% of flowcommon stockSEC:0000891293-23-000003:0
3 of 3 declarations
